<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/78308CAA-8483-45C0-A280-0AB4B6AD9D35"><gtr:id>78308CAA-8483-45C0-A280-0AB4B6AD9D35</gtr:id><gtr:name>Medical Research Council</gtr:name><gtr:address><gtr:line1>Polaris House</gtr:line1><gtr:line2>North Star Avenue</gtr:line2><gtr:postCode>SN2 1FL</gtr:postCode><gtr:region>South West</gtr:region></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/E1649C06-DC81-4A08-8A23-F5B65BB6C670"><gtr:id>E1649C06-DC81-4A08-8A23-F5B65BB6C670</gtr:id><gtr:name>Babraham Institute</gtr:name><gtr:department>Lymphocyte Signalling and Development</gtr:department><gtr:address><gtr:line1>Babraham Research Campus</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:line5>Cambridgeshire</gtr:line5><gtr:postCode>CB22 3AT</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/E1649C06-DC81-4A08-8A23-F5B65BB6C670"><gtr:id>E1649C06-DC81-4A08-8A23-F5B65BB6C670</gtr:id><gtr:name>Babraham Institute</gtr:name><gtr:address><gtr:line1>Babraham Research Campus</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:line5>Cambridgeshire</gtr:line5><gtr:postCode>CB22 3AT</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role><gtr:role><gtr:name>FELLOW</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/78308CAA-8483-45C0-A280-0AB4B6AD9D35"><gtr:id>78308CAA-8483-45C0-A280-0AB4B6AD9D35</gtr:id><gtr:name>Medical Research Council</gtr:name><gtr:address><gtr:line1>Polaris House</gtr:line1><gtr:line2>North Star Avenue</gtr:line2><gtr:postCode>SN2 1FL</gtr:postCode><gtr:region>South West</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/DBA15943-8B45-46D9-873F-346B6F0996FB"><gtr:id>DBA15943-8B45-46D9-873F-346B6F0996FB</gtr:id><gtr:firstName>Elena</gtr:firstName><gtr:surname>Vigorito</gtr:surname><gtr:roles><gtr:role><gtr:name>FELLOW</gtr:name></gtr:role><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0700287"><gtr:id>BAA1C3CB-BB30-481E-BFE8-1B4CD7B17558</gtr:id><gtr:title>Analysis of microRNA function in B lymphocytes.</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Fellowship</gtr:grantCategory><gtr:grantReference>G0700287</gtr:grantReference><gtr:abstractText>B lymphocytes are a type of white blood cells. They provide long term immunity following disease or vaccination, being therefore essential for normal health. Deregulation of B lymphocytes may lead to autoimmune diseases or cancer. Consequently, understanding the molecular mechanisms of B cell differentiation is an important priority. 

MicroRNAs are a recently discovered type of molecule increasingly recognised as being essential for many biological processes. Until recently, nothing has been known on the role of specific microRNAs in B lymphocyte differentiation, but it is anticipated that microRNAs will be shown to be important regulators of B cell function. In this regard, I have observed that one microRNA, miR-155, regulates important functions of B cells necessary for antibody secretion. This project is designed to gain a better understanding of how this and other microRNAs work. MicroRNA expression is altered in cancer and it is likely that in the future pharmaceutical companies will target them. The knowledge obtained from my proposed work will provide insights into a new mechanism regulating lymphocyte differentiation which in the long term may impact on the design of therapies for treatment of human diseases</gtr:abstractText><gtr:technicalSummary>MicroRNAs (miRNAs) are increasingly being recognised as major regulators of gene expression. They provide an additional level of regulation beyond transcriptional control, permitting more rapid establishment of stable gene expression patterns. MiR-155 is encoded within an exon of the bic non-coding RNA transcript and is highly expressed in antigen receptor-activated B lymphocytes. 

During the course of adaptive immune responses B lymphocytes must respond rapidly to antigenic stimulation by initiating complex changes in gene expression that allow differentiation into effector and memory cells. These events lead to the production of high affinity antibodies and development of lasting immunological protection which underpins effective vaccination. 

My previous work has implicated bic/miR-155 in optimal adaptive immune responses of B cells in a cell-autonomous manner. Those results led me to propose that bic/miR-155 regulates the selection of high affinity germinal centre B cells to become plasma cells. In this project, an integrative approach combining cellular biology, biochemical and bioinformatics methodologies aims to test this hypothesis and to provide further mechanistic insights by identifying miR-155 target genes. Furthermore, I have previously identified a group of miRNAs differentially regulated during B cell development. I will use synthetic molecules which can specifically antagonise miRNAs (antagomirs) to determine how this group of miRNAs control B cell function.

MiRNAs appear to be deregulated in certain forms of cancer: miR-155 is an example of a miRNA with oncogenic potential. Although the prospect of targeting miRNAs for therapeutic use is exciting, more research is needed to assess their validity in the clinic. In particular, a deep understanding of specific miRNA function in health is essential to provide insights into the underlying mechanisms of oncogenesis. Only by understanding the normal biological processes regulated by miRNAs and their network of target genes will it be possible to safely unlock their full potential for pharmaceutical intervention in the treatment of human diseases.</gtr:technicalSummary><gtr:fund><gtr:end>2013-02-28</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2007-09-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>960428</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Medical Research Council (MRC)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>MRC Laboratory of Molecular Biology (LMB)</gtr:department><gtr:description>Targeting miRNAs with oligonucleotides</gtr:description><gtr:id>8CE213D7-7662-4E69-A6FF-949616C8D87B</gtr:id><gtr:impact>Two papers (listed in publication list). Another one submitted.</gtr:impact><gtr:outcomeId>rCDegWZed8B-1</gtr:outcomeId><gtr:partnerContribution>Production of oligonucleotides and expertise in synthesis and delivery</gtr:partnerContribution><gtr:piContribution>Study the effectiveness of oligonucleotides to target miRNAs in mice</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>school teachers visiting babraham institute</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:id>73F764A9-0D42-4120-9CCD-A85DA85F7E56</gtr:id><gtr:impact>20 teachers attended scientific talks

the scheme will be repeated this year</gtr:impact><gtr:outcomeId>kBhcvapds4j</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2009</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Students visit at BI</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>B56CE9DE-94BD-4C3E-97E8-C6C7D72A04DD</gtr:id><gtr:impact>groups of 10-12 students attended hands-on lab work which inspired pupils to work in science

Schools asked to repeat the experience</gtr:impact><gtr:outcomeId>GAzUdiEpRnE</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Workshop Facilitator</gtr:presentationType><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2009,2010,2011,2012</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>780869</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Project grant</gtr:description><gtr:end>2014-09-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>6C19C084-C82D-4CF1-9B86-419EB28BDFC3</gtr:id><gtr:outcomeId>ZQvPq3WjXw50</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-09-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>08D3598B-C8DB-4CD9-9FB6-F9E97D10E9D7</gtr:id><gtr:title>Epstein-Barr nuclear antigen 1 induces expression of the cellular microRNA hsa-miR-127 and impairing B-cell differentiation in EBV-infected memory B cells. New insights into the pathogenesis of Burkitt lymphoma.</gtr:title><gtr:parentPublicationTitle>Blood cancer journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1bcf757d66906f1d56d16965cae7c9eb"><gtr:id>1bcf757d66906f1d56d16965cae7c9eb</gtr:id><gtr:otherNames>Onnis A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>2044-5385</gtr:issn><gtr:outcomeId>pm_14154_24_22941339</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3AF19F34-E075-487D-B573-D6D234706437</gtr:id><gtr:title>MiR-25 regulates Wwp2 and Fbxw7 and promotes reprogramming of mouse fibroblast cells to iPSCs.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b547807318acd5f0dc3ba27c7fe7636a"><gtr:id>b547807318acd5f0dc3ba27c7fe7636a</gtr:id><gtr:otherNames>Lu D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>pm_14154_24_22912667</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F94F7F99-A3CC-4525-B7B3-BC6F9E8081AC</gtr:id><gtr:title>Noncoding RNA and its associated proteins as regulatory elements of the immune system.</gtr:title><gtr:parentPublicationTitle>Nature immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d6908988a9a607232738eabea8393d78"><gtr:id>d6908988a9a607232738eabea8393d78</gtr:id><gtr:otherNames>Turner M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1529-2908</gtr:issn><gtr:outcomeId>54185abd945680.97217772</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AF4BB990-33D8-40CD-8A05-626F35ACA705</gtr:id><gtr:title>The miR-155-PU.1 axis acts on Pax5 to enable efficient terminal B cell differentiation.</gtr:title><gtr:parentPublicationTitle>The Journal of experimental medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b547807318acd5f0dc3ba27c7fe7636a"><gtr:id>b547807318acd5f0dc3ba27c7fe7636a</gtr:id><gtr:otherNames>Lu D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0022-1007</gtr:issn><gtr:outcomeId>546390bb012c18.25052617</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C2DDA61A-EF7E-41C1-895F-0AC8B9FA2282</gtr:id><gtr:title>Efficient inhibition of miR-155 function in vivo by peptide nucleic acids.</gtr:title><gtr:parentPublicationTitle>Nucleic acids research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/00a5eca76151c76f54001f781d91b442"><gtr:id>00a5eca76151c76f54001f781d91b442</gtr:id><gtr:otherNames>Fabani MM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0305-1048</gtr:issn><gtr:outcomeId>j17nHoiuDKZ</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>70D1E085-E1F1-4E6F-A434-D4C6F0B021D2</gtr:id><gtr:title>MicroRNA-155 controls affinity-based selection by protecting c-MYC+ B cells from apoptosis.</gtr:title><gtr:parentPublicationTitle>The Journal of clinical investigation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bb288c1f5870c43259008f17fc02a375"><gtr:id>bb288c1f5870c43259008f17fc02a375</gtr:id><gtr:otherNames>Nakagawa R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0021-9738</gtr:issn><gtr:outcomeId>585d66ae8dbba5.93314238</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9DE48DE5-8E8C-46BA-BEB7-EC09131485A5</gtr:id><gtr:title>miRNA-155 controls mast cell activation by regulating the PI3K? pathway and anaphylaxis in a mouse model.</gtr:title><gtr:parentPublicationTitle>Allergy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c0aaf6ec12208981c4eaf7e4c71b127f"><gtr:id>c0aaf6ec12208981c4eaf7e4c71b127f</gtr:id><gtr:otherNames>Biethahn K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0105-4538</gtr:issn><gtr:outcomeId>54185abdcb95a3.28877841</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>312BC7DD-B376-4A51-98B3-326919474F38</gtr:id><gtr:title>MicroRNA fate upon targeting with anti-miRNA oligonucleotides as revealed by an improved Northern-blot-based method for miRNA detection.</gtr:title><gtr:parentPublicationTitle>RNA (New York, N.Y.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/84858b1e9f1f73d623822d7a590fb2dd"><gtr:id>84858b1e9f1f73d623822d7a590fb2dd</gtr:id><gtr:otherNames>Torres AG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1355-8382</gtr:issn><gtr:outcomeId>cH43DUNPxhS</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E0B5206C-94DD-40E7-B808-007DBD6794A2</gtr:id><gtr:title>microRNA-155 regulates the generation of immunoglobulin class-switched plasma cells.</gtr:title><gtr:parentPublicationTitle>Immunity</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ba11c6db7f4c1011f6d86abb62b41938"><gtr:id>ba11c6db7f4c1011f6d86abb62b41938</gtr:id><gtr:otherNames>Vigorito E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1074-7613</gtr:issn><gtr:outcomeId>5876B44F2C8</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7F6DBF9D-C87C-43F9-9C4D-A4B4892AD161</gtr:id><gtr:title>Cutting edge: the Foxp3 target miR-155 contributes to the development of regulatory T cells.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1fe6f280971b7a1152ee3e5d2522299a"><gtr:id>1fe6f280971b7a1152ee3e5d2522299a</gtr:id><gtr:otherNames>Kohlhaas S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn><gtr:outcomeId>71B6A41DF42</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>78ED8A14-A234-41D8-A496-8D0431FB5959</gtr:id><gtr:title>HVCN1 modulates BCR signal strength via regulation of BCR-dependent generation of reactive oxygen species.</gtr:title><gtr:parentPublicationTitle>Nature immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f84a595d1ec65fe050e4f11ea28f208f"><gtr:id>f84a595d1ec65fe050e4f11ea28f208f</gtr:id><gtr:otherNames>Capasso M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1529-2908</gtr:issn><gtr:outcomeId>ndoWGSsthHs</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3417A342-35B2-4826-9925-036C753A8FB5</gtr:id><gtr:title>miR-155: an ancient regulator of the immune system.</gtr:title><gtr:parentPublicationTitle>Immunological reviews</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ba11c6db7f4c1011f6d86abb62b41938"><gtr:id>ba11c6db7f4c1011f6d86abb62b41938</gtr:id><gtr:otherNames>Vigorito E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0105-2896</gtr:issn><gtr:outcomeId>pm_14154_24_23550644</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0700287</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>C6D70A71-8796-47BC-AFE0-CC2286E66A06</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Inflammatory and Immune System</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>CF950C9A-DB16-4E23-8AEB-94548777BCA1</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>1.1  Normal biological development and functioning</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>